A randomized phase-I pharmacokinetic trial comparing the potential biosimilar tocilizumab (QX003S) with the reference product (Actemra(R)) in Chinese healthy subjects

Zhang, H; Li, XJ; Liu, JR; Li, CY; Wu, M; Zhu, XX; Sun, JX; Fang, M; Ding, YH

Ding, YH (corresponding author), Jilin Univ, Hosp 1, Phase Clin Trial Unit 1, Changchun 130021, Peoples R China.

ANNALS OF MEDICINE, 2021; 53 (1): 375

Abstract

Purpose: QX003S is a biosimilar candidate for the reference tocilizumab, Actemra (R). We investigated the tolerance, variability, and pharmacokinetics......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索